Neuropeptides and Their Roles in the Cerebellum

• Published in: International journal of molecular sciences Vol. 25; no. 4; p. 2332
• Main Authors: Li, Zi-Hao, Li, Bin, Zhang, Xiao-Yang, Zhu, Jing-Ning
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.02.2024
• Subjects: ACTH; Autism; Brain; Brain-derived neurotrophic factor; Cell cycle; cerebellar ataxia; Cerebellar Cortex - metabolism; cerebellar development; Cerebellar Diseases - pathology; cerebellum; Cerebellum - metabolism; Hormones; Humans; Kinases; Mental illness; motor coordination; Nervous system diseases; Neurons; Neurons - metabolism; neuropeptide; Neuropeptides; Neuropeptides - metabolism; Purkinje Cells - metabolism; cerebellar ataxia; motor learning; cerebellar development; neuropeptide; synaptic plasticity; autism; cerebellum; motor coordination
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25042332

Although more than 30 different types of neuropeptides have been identified in various cell types and circuits of the cerebellum, their unique functions in the cerebellum remain poorly understood. Given the nature of their diffuse distribution, peptidergic systems are generally assumed to exert a modulatory effect on the cerebellum via adaptively tuning neuronal excitability, synaptic transmission, and synaptic plasticity within cerebellar circuits. Moreover, cerebellar neuropeptides have also been revealed to be involved in the neurogenetic and developmental regulation of the developing cerebellum, including survival, migration, differentiation, and maturation of the Purkinje cells and granule cells in the cerebellar cortex. On the other hand, cerebellar neuropeptides hold a critical position in the pathophysiology and pathogenesis of many cerebellar-related motor and psychiatric disorders, such as cerebellar ataxias and autism. Over the past two decades, a growing body of evidence has indicated neuropeptides as potential therapeutic targets to ameliorate these diseases effectively. Therefore, this review focuses on eight cerebellar neuropeptides that have attracted more attention in recent years and have significant potential for clinical application associated with neurodegenerative and/or neuropsychiatric disorders, including brain-derived neurotrophic factor, corticotropin-releasing factor, angiotensin II, neuropeptide Y, orexin, thyrotropin-releasing hormone, oxytocin, and secretin, which may provide novel insights and a framework for our understanding of cerebellar-related disorders and have implications for novel treatments targeting neuropeptide systems.